Published in Thromb Haemost on May 03, 1993
A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature (2000) 47.15
Life with 6000 genes. Science (1996) 41.51
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1984) 20.61
Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care (2005) 12.73
A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol Rev (1987) 7.00
Internists' attitudes about clinical practice guidelines. Ann Intern Med (1994) 6.55
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Natl Acad Sci U S A (2001) 5.19
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
Inability of trained nurses to perform basic life support. Br Med J (Clin Res Ed) (1987) 5.08
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Cerebral sinovenous thrombosis in children. N Engl J Med (2001) 4.81
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med (1996) 4.70
Green fluorescent protein as a marker for gene expression and subcellular localization in budding yeast. Yeast (1996) 4.53
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med (1997) 4.47
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg (1997) 4.47
Surveying Saccharomyces genomes to identify functional elements by comparative DNA sequence analysis. Genome Res (2001) 4.22
Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy. Br J Surg (2012) 4.01
Do sick newborn infants benefit from participation in a randomized clinical trial? J Pediatr (1999) 3.98
Function and regulation of yeast hexose transporters. Microbiol Mol Biol Rev (1999) 3.96
Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord (2000) 3.90
Three different regulatory mechanisms enable yeast hexose transporter (HXT) genes to be induced by different levels of glucose. Mol Cell Biol (1995) 3.74
Two glucose transporters in Saccharomyces cerevisiae are glucose sensors that generate a signal for induction of gene expression. Proc Natl Acad Sci U S A (1996) 3.54
Accuracy of clinical assessment of deep-vein thrombosis. Lancet (1995) 3.45
Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science (1991) 3.41
Disability: a model and measurement technique. Br J Prev Soc Med (1976) 3.41
Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis. Clin Oncol (R Coll Radiol) (2002) 3.33
Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut (2010) 3.24
Application of operant conditioning procedures to the behavior problems of an autistic child: a follow-up and extension. Behav Res Ther (1967) 3.23
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (1994) 3.12
Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression. Proc Natl Acad Sci U S A (1991) 3.00
Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle. EMBO J (1997) 2.97
Regulated nuclear translocation of the Mig1 glucose repressor. Mol Biol Cell (1997) 2.96
Glucose sensing and signaling by two glucose receptors in the yeast Saccharomyces cerevisiae. EMBO J (1998) 2.96
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med (1988) 2.85
Genetic evidence that zinc is an essential co-factor in the DNA binding domain of GAL4 protein. Nature (1987) 2.71
Development of the human coagulation system in the full-term infant. Blood (1987) 2.69
Two systems of glucose repression of the GAL1 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1990) 2.65
Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev (2007) 2.52
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med (2001) 2.35
GRR1 of Saccharomyces cerevisiae is required for glucose repression and encodes a protein with leucine-rich repeats. Mol Cell Biol (1991) 2.34
Changing clinicians' behavior: a randomized controlled trial of fees and education. J Dent Res (2008) 2.34
The work of a clinical psychologist in primary care. J R Coll Gen Pract (1978) 2.31
Establishing a therapeutic range for heparin therapy. Ann Intern Med (1993) 2.31
Characterization of three related glucose repressors and genes they regulate in Saccharomyces cerevisiae. Genetics (1998) 2.27
Baseline staging tests in primary breast cancer: a practice guideline. CMAJ (2001) 2.22
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost (2004) 2.21
Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics (1995) 2.14
tRNA genes as transcriptional repressor elements. Mol Cell Biol (1994) 2.10
Predictors of emotional outcomes of intensive care. Anaesthesia (2005) 2.10
The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women. J Psychosom Res (1989) 2.06
Galactose as a gratuitous inducer of GAL gene expression in yeasts growing on glucose. Gene (1989) 2.04
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
Two zinc-finger-containing repressors are responsible for glucose repression of SUC2 expression. Mol Cell Biol (1996) 1.92
Venous thromboembolic complications in children. J Pediatr (1993) 1.92
Maturation of the hemostatic system during childhood. Blood (1992) 1.89
The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of Saccharomyces cerevisiae. Curr Biol (1999) 1.89
Mutations that inactivate a yeast transcriptional regulatory protein cluster in an evolutionarily conserved DNA binding domain. Proc Natl Acad Sci U S A (1987) 1.86
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res (2000) 1.86
Rgt1p of Saccharomyces cerevisiae, a key regulator of glucose-induced genes, is both an activator and a repressor of transcription. Mol Cell Biol (1996) 1.85
Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol (1990) 1.78
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med (1998) 1.76
Educational package on hypertension for primary care physicians. Can Med Assoc J (1984) 1.73
The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr (2000) 1.72
Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ (2001) 1.71
Does motor imagery training improve hand function in chronic stroke patients? A pilot study. Clin Rehabil (2004) 1.69
Chickenpox and stroke in childhood: a study of frequency and causation. Stroke (2001) 1.69
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1985) 1.67
Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev (2006) 1.67
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med (1986) 1.67
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr (1993) 1.64
Analysis of URSG-mediated glucose repression of the GAL1 promoter of Saccharomyces cerevisiae. Genetics (1992) 1.64
Molecular cloning of the GAL80 gene from Saccharomyces cerevisiae and characterization of a gal80 deletion. Gene (1984) 1.64
Development of a self-administered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests. J Psychosom Res (1988) 1.60
Laparoscopic restorative proctocolectomy. Br J Surg (2005) 1.60
Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest (1998) 1.59
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemost (2001) 1.58
Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr (1998) 1.58
Development of the human coagulation system in the healthy premature infant. Blood (1988) 1.57
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Isolation and characterization of the ZWF1 gene of Saccharomyces cerevisiae, encoding glucose-6-phosphate dehydrogenase. Gene (1990) 1.57
Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. Blood (1992) 1.55
The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn (1992) 1.53
Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood (1993) 1.52
Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. Eur Heart J (2002) 1.51
Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br J Surg (2014) 1.50
Expression of the SUC2 gene of Saccharomyces cerevisiae is induced by low levels of glucose. Yeast (1997) 1.49
Frequency and mechanism of neonatal thrombocytopenia. J Pediatr (1986) 1.49
Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost (1996) 1.48
Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med (2004) 1.48
Screening for Down's syndrome. BMJ (1988) 1.48